In this Supplement
How to React in the SFA
Properly preparing lesions before use of drug-eluting technologies has become a crucial step of the treatment algorithm.
By Ralf Langhoff, MD
The technology and clinical outcomes of the Passeo-18 Lux DCB.
By Marianne Brodmann, MD; and Gunnar Tepe, MD
Clinical outcomes in treatment of femoropopliteal artery disease with the Pulsar-18 stent.
By Jos C. van den Berg, MD, PhD; and Michael Lichtenberg, MD, FESC
Combining a Drug-Coated Balloon and a Bare-Metal Stent: The REsponse Adapted Combination Therapy (REACT) Strategy
Allowing vessel response to guide appropriate treatment for SFA disease.
By Koen Deloose, MD, and B. Patrice Mwipatayi, MD, MMed, MClinEd, FCS, FRACS
The difficulties in weighing cost-effectiveness in treatment algorithms remain.